Delta Sleep-Inducing Peptide (DSIP) 2 mg (1 vial)

The research utility of DSIP Peptide extends beyond mere sleep induction; it is considered a multi-modal regulator that influences the body’s homeostatic balance during periods of stress and neurological transition.

Key Areas of Experimental Focus:

• Delta Sleep Induction: Studies in mammals have observed DSIP’s ability to promote the onset of deep, non-REM (Delta) sleep. Researchers focus on how it interacts with NMDA receptors and the GABAergic system to stabilize neuronal activity.

• Circadian & Locomotor Patterns: DSIP is used in models to investigate the synchronization of the biological clock. Research indicates it may influence the rhythmic secretion of hormones and the stabilization of locomotor patterns in disrupted circadian environments.

• Neuropharmacological Withdrawal: A significant area of interest involves DSIP’s effect on the withdrawal of pharmacological substances. Experimental data suggests it may mitigate the physiological and psychological stress markers associated with the cessation of opioids and alcohol.

• Hormonal Regulation: Research has observed DSIP’s ability to influence the endocrine system, specifically the suppression of ACTH (Adrenocorticotropic hormone) and cortisol, while potentially stimulating the release of LH (Luteinizing Hormone).

Chemical & Technical Specifications